Abstract: Embodiments of the present invention disclose a foot mirror assembly having a camera for capturing photos of a foot of a user which provide the user an improved view of the foot for diabetic foot exams. The assembly includes a frame member, a standing member, a mirror coupled with the frame member, a set of lights located on the frame member. Other embodiments include an electronic device coupled with the frame member, the electronic device having a camera. In further embodiments, the electronic device transmits captured photographs to a remote device.

Abstract: This invention relates to the discovery of novel rosuvastatin analogs. More specifically, the invention relates to novel rosuvastatin analogs which have utility in treating conditions treatable by the inhibition of HMG-CoA reductase.

Abstract: This invention relates to the discovery of novel rosuvastatin and atorvastatin analogues.

Abstract: The present invention relates to derivatives of compounds which are known to be of use in the field of agriculture. These derivatives are differentiated from the parent active compound by virtue of being redox derivatives of the active compound. This means that one or more of the functional groups in the active compound has been converted to another group in one or more changes one or more of which may be considered to represent a change of oxidation state relative to the groups in the original compound. We refer to these compounds generally as redox derivatives. The compounds are of use as insecticides, herbicides and insect repellents.

Abstract: The present invention relates to derivatives of known active pharmaceutical compounds. These derivatives are differentiated from the parent active compound by virtue of being redox derivatives of the active compound. This means that one or more of the functional groups in the active compound has been converted to another group in one or more reactions which may be considered to represent a change of oxidation state. We refer to these compounds generally as redox derivatives. The derivatives of the invention may be related to the original parent active pharmaceutical compound by only a single step transformation, or may be related via several synthetic steps including one or more changes of oxidation state.

Abstract: The present invention provides redox drug derivatives. In particular, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, (3R,4R,5S)-4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester, (3S)-3-(aminomethyl)-5-methylhexanoic acid, (3S)-1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-?-?-diphenyl-3-pyrrolidineacetamide, (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethyl-butyl]-4-(diaminomethylideneamino)-2-hydroxy-cyclopentane-1-carboxylic acid and (2R,3R,4S)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid redox derivatives.

Abstract: This invention relates to the discovery of novel rosuvastatin analogues. More specifically, the invention relates to novel rosuvastatin analogues which have utility in treating conditions treatable by the inhibition of HMG-CoA reductase.

Abstract: This invention relates to the discovery of novel rosuvastatin and atorvastatin analogues.

Abstract: The present invention relates to derivatives of known active pharmaceutical compounds. These derivatives are differentiated from the parent active compound by virtue of being redox derivatives of the active compound. This means that one or more of the functional groups in the active compound has been converted to another group in one or more reactions which may be considered to represent a change of oxidation state. We refer to these compounds generally as redox derivatives. The derivatives of the invention may be related to the original parent active pharmaceutical compound by only a single step transformation, or may be related via several synthetic steps including one or more changes of oxidation state. In certain cases, the functional group obtained after two or more transformations may be in the same oxidation state as the parent active compound (and we include these compounds in our definition of redox derivatives).

Abstract: This invention relates to the discovery of novel rosuvastatin and atorvastatin analogues.

Abstract: The present invention provides redox drug derivatives. In particular, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, (3R,4R,5S)-4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester, (3S)-3-(aminomethyl)-5-methylhexanoic acid, (3S)-1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-?-?-diphenyl-3-pyrrolidineacetamide, (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethyl-butyl]-4-(diaminomethylideneamino)-2-hydroxy-cyclopentane-1-carboxylic acid and (2R,3R,4S)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid redox derivatives.

Abstract: This invention relates to the discovery of novel rosuvastatin analogues. More specifically, the invention relates to novel rosuvastatin analogues which have utility in treating conditions treatable by the inhibition of HMG-CoA reductase.

Abstract: This invention relates to the discovery of novel atorvastatin analogues. More specifically, the invention relates to novel atorvastatin analogues which have utility in treating conditions treatable by the inhibition of HMG-CoA reductase.

Abstract: This invention relates to the discovery of novel rosuvastatin and atorvastatin analogues.

Abstract: A method of loading a child or child seat into a vehicle is disclosed. A user can rotate the rear-most vehicle seat toward the rear of the vehicle and load the child and/or child seat from the rear opening.

Abstract: A vehicle seat that is foldable can include a linkage mechanism for operatively withdrawing the headrest during fold down procedures and automatically extending the headrest to a use position during unfolding procedures of the seat.

Abstract: A seatbelt retractor for storing seatbelt webbing that can be utilized to restrain an occupant of a motor vehicle. The retractor includes a retractor frame and a plurality of spools rotatably coupled to the retractor frame and spaced a distance apart from each other. Seatbelt webbing can be withdrawn from the seatbelt retractor to extend about an occupant of a seat of the motor vehicle and releasably coupled to a buckle provided to the motor vehicle in a withdrawn state, and collected by the seatbelt retractor in a retracted state. A length of the seatbelt webbing adjacent to a terminal end thereof is collected at least partially around the plurality of spools in the retracted state.

Abstract: The present invention generally relates to tray table devices and related methods. Some embodiments include foldable tray table devices capable of being stowed. Some embodiments also include tray tables that have expandable and/or collapsible storage compartments. Other embodiments relate to methods for making and/or using structural embodiments of the invention.

Abstract: A vehicle seat assembly includes an anti-backlash mechanism in the seat adjustment gearing to reduce or eliminate gaps that cause looseness in the gearing.

Abstract: The present invention generally relates to self-aligning electrical coupling devices and related methods. For example, one embodiment can include an aligning means for aligning a central axis of a male connector component with a central axis of a female connector component. The embodiment can also include a rotationally-aligning means for rotationally aligning a male connector component with a female connector component so as to achieve a predetermined rotational orientation. Some embodiments can also an electrically-communicating means for electrically communicating between the male connector component and the female connector component. Some embodiments relate to processes for assembling self-aligning electrical coupling device.